Quote:

---

Aren't you projecting on things not known?
$1b revenue?

---

What we do know. There are currently 6.9 million Americans suffering from Alzheimer's and that is projected to grow larger. There are no really effective treatment options which means the entire market is up for grabs. The $32,000 a year price for leronlimab I projected back in 2019 is still viable. Which would mean total potential revenue would be $220 billion. Not everyone will be using leronlimab but I think $1 billion is very conservative.

Quote:

---

If the foundation chooses to forward fund, it changes your this or that pickle.

My bet, they don't just pack up & go home if great, not good, great results.

Quote:

---

I had thought of that. The NIH or an Alzheimer's foundation is probably backing that study and would be willing to fund a trial. My proposal was in case there was no outside funding.

---

---